ABCL Abcellera Biologics Inc

held by 1 manager in Q2 2023

Manager	% of their portfolio	Held	Activity	Value	Shares
Stanley Druckenmiller Duquesne Family Office	0.15%	2.0 yr	—	$4M	659,750

Search